AGP Executive Report
Last update: an hour agoDementia Breakthrough: A Phase 2 trial at the Alzheimer’s Association conference reports a CBD+THC oral treatment easing agitation in late-stage dementia—about 84% improved after two weeks, rising to nearly 90% by 12 weeks. Rescheduling Reality Check: A Penn State Q&A says Schedule III medical marijuana doesn’t automatically create a national market; state rules still drive access, even as DEA rescheduling talk continues. Policy Push in Congress: UFCW backs the Cannabis Administration and Opportunity Act, arguing federal workplace protections and better jobs are key as legalization expands. Legal Market Update: A Michigan judge lifted an injunction that could allow Menominee to issue a ninth marijuana license, leaving the decision to the city. Health & Behavior Study: Research in the Journal of Affective Disorders links cannabis use in young adults at bipolar risk to more disruption in daily responsibilities, not necessarily higher use. Enforcement & Trade: NDLEA reports intercepting 1.63M tramadol pills and also seizing “Canadian Loud” cannabis tied to cross-border trafficking. Consumer Safety Warning: UK Border Force warns young travelers against “free holiday” grooming schemes used to smuggle cannabis into the country.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
